Histone deacetylase inhibition reduces pulmonary vein arrhythmogenesis through calcium regulation

Baigalmaa Lkhagva, Shih Lin Chang, Yao Chang Chen, Yu Hsun Kao, Yung Kuo Lin, Cindy Tzu Hsuan Chiu, Shih Ann Chen, Yi Jen Chen

研究成果: 雜誌貢獻文章

11 引文 (Scopus)

摘要

Pulmonary veins (PVs) play a critical role in the pathophysiology of atrial fibrillation (AF). Histone deacetylases (HDACs) are vital to calcium homeostasis and AF genesis. However, the electrophysiological effects of HDAC inhibition were unclear. This study evaluated whether HDAC inhibition can regulate PV electrical activity through calcium modulation. Whole-cell patch-clamp, confocal microscopic with fluorescence, and Western blot were used to evaluate electrophysiological characteristics and Ca2 + dynamics in isolated rabbit PV cardiomyocytes with and without MPT0E014 (a pan HDAC inhibitor), MS-275 (HDAC1 and 3 inhibitor), and MC-1568 (HDAC4 and 6 inhibitor) for 5 ~ 8 h. Atrial electrical activity and induced-AF (rapid atrial pacing and acetylcholine infusion) were measured in rabbits with and without MPT0E014 (10 mg/kg treated for 5 hours) in vivo. MPT0E014 (1 μM)-treated PV cardiomyocytes (n = 12) had slower beating rates (2.1 ± 0.2 vs. 2.8 ± 0.1 Hz, p <0.05) than control PV cardiomyocytes. However, control (n = 11) and MPT0E014 (1 μM)-treated (n = 12) SAN cardiomyocytes had similar beating rates (3.2 ± 0.2 vs. 2.9 ± 0.3 Hz). MS-275-treated PV cardiomyocytes (n = 12, 2.3 ± 0.2 Hz), but not MC-1568-treated PV cardiomyocytes (n = 14, 3.1 ± 0.3 Hz) had slower beating rates than control PV cardiomocytes. MPT0E014-treated PV cardiomyocytes (n = 14) had a lower frequency (2.4 ± 0.6 vs. 0.3 ± 0.1 spark/mm/s, p <0.05) of Ca2 + sparks than control PV (n = 17) cardiomyocytes. As compared to control, MPT0E014-treated PV cardiomyocytes had reduced Ca2 + transient amplitudes, sodium-calcium exchanger currents, and ryanodine receptor expressions. Moreover, MPT0E014-treated rabbits had less AF and shorter AF duration than control rabbits. In conclusions, HDAC inhibition reduced PV arrhythmogenesis and AF inducibility with modulation on calcium homeostasis.. All rights reserved.

原文英語
頁(從 - 到)982-989
頁數8
期刊International Journal of Cardiology
177
發行號3
DOIs
出版狀態已發佈 - 十二月 20 2014

指紋

Histone Deacetylases
Pulmonary Veins
Cardiac Myocytes
Calcium
Atrial Fibrillation
Rabbits
Homeostasis
Sodium-Calcium Exchanger
Ryanodine Receptor Calcium Release Channel
3-(1-benzenesulfonyl-1H-indol-5-yl)-N-hydroxyacrylamide
Acetylcholine
Fluorescence
Western Blotting

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

引用此文

Histone deacetylase inhibition reduces pulmonary vein arrhythmogenesis through calcium regulation. / Lkhagva, Baigalmaa; Chang, Shih Lin; Chen, Yao Chang; Kao, Yu Hsun; Lin, Yung Kuo; Chiu, Cindy Tzu Hsuan; Chen, Shih Ann; Chen, Yi Jen.

於: International Journal of Cardiology, 卷 177, 編號 3, 20.12.2014, p. 982-989.

研究成果: 雜誌貢獻文章

Lkhagva, Baigalmaa ; Chang, Shih Lin ; Chen, Yao Chang ; Kao, Yu Hsun ; Lin, Yung Kuo ; Chiu, Cindy Tzu Hsuan ; Chen, Shih Ann ; Chen, Yi Jen. / Histone deacetylase inhibition reduces pulmonary vein arrhythmogenesis through calcium regulation. 於: International Journal of Cardiology. 2014 ; 卷 177, 編號 3. 頁 982-989.
@article{d135fca11f664b00b99770e8f8c706ae,
title = "Histone deacetylase inhibition reduces pulmonary vein arrhythmogenesis through calcium regulation",
abstract = "Pulmonary veins (PVs) play a critical role in the pathophysiology of atrial fibrillation (AF). Histone deacetylases (HDACs) are vital to calcium homeostasis and AF genesis. However, the electrophysiological effects of HDAC inhibition were unclear. This study evaluated whether HDAC inhibition can regulate PV electrical activity through calcium modulation. Whole-cell patch-clamp, confocal microscopic with fluorescence, and Western blot were used to evaluate electrophysiological characteristics and Ca2 + dynamics in isolated rabbit PV cardiomyocytes with and without MPT0E014 (a pan HDAC inhibitor), MS-275 (HDAC1 and 3 inhibitor), and MC-1568 (HDAC4 and 6 inhibitor) for 5 ~ 8 h. Atrial electrical activity and induced-AF (rapid atrial pacing and acetylcholine infusion) were measured in rabbits with and without MPT0E014 (10 mg/kg treated for 5 hours) in vivo. MPT0E014 (1 μM)-treated PV cardiomyocytes (n = 12) had slower beating rates (2.1 ± 0.2 vs. 2.8 ± 0.1 Hz, p <0.05) than control PV cardiomyocytes. However, control (n = 11) and MPT0E014 (1 μM)-treated (n = 12) SAN cardiomyocytes had similar beating rates (3.2 ± 0.2 vs. 2.9 ± 0.3 Hz). MS-275-treated PV cardiomyocytes (n = 12, 2.3 ± 0.2 Hz), but not MC-1568-treated PV cardiomyocytes (n = 14, 3.1 ± 0.3 Hz) had slower beating rates than control PV cardiomocytes. MPT0E014-treated PV cardiomyocytes (n = 14) had a lower frequency (2.4 ± 0.6 vs. 0.3 ± 0.1 spark/mm/s, p <0.05) of Ca2 + sparks than control PV (n = 17) cardiomyocytes. As compared to control, MPT0E014-treated PV cardiomyocytes had reduced Ca2 + transient amplitudes, sodium-calcium exchanger currents, and ryanodine receptor expressions. Moreover, MPT0E014-treated rabbits had less AF and shorter AF duration than control rabbits. In conclusions, HDAC inhibition reduced PV arrhythmogenesis and AF inducibility with modulation on calcium homeostasis.. All rights reserved.",
keywords = "Atrial fibrillation, Calcium homeostasis, Histone deacetylase inhibition, Pulmonary vein",
author = "Baigalmaa Lkhagva and Chang, {Shih Lin} and Chen, {Yao Chang} and Kao, {Yu Hsun} and Lin, {Yung Kuo} and Chiu, {Cindy Tzu Hsuan} and Chen, {Shih Ann} and Chen, {Yi Jen}",
year = "2014",
month = "12",
day = "20",
doi = "10.1016/j.ijcard.2014.09.175",
language = "English",
volume = "177",
pages = "982--989",
journal = "International Journal of Cardiology",
issn = "0167-5273",
publisher = "Elsevier Ireland Ltd",
number = "3",

}

TY - JOUR

T1 - Histone deacetylase inhibition reduces pulmonary vein arrhythmogenesis through calcium regulation

AU - Lkhagva, Baigalmaa

AU - Chang, Shih Lin

AU - Chen, Yao Chang

AU - Kao, Yu Hsun

AU - Lin, Yung Kuo

AU - Chiu, Cindy Tzu Hsuan

AU - Chen, Shih Ann

AU - Chen, Yi Jen

PY - 2014/12/20

Y1 - 2014/12/20

N2 - Pulmonary veins (PVs) play a critical role in the pathophysiology of atrial fibrillation (AF). Histone deacetylases (HDACs) are vital to calcium homeostasis and AF genesis. However, the electrophysiological effects of HDAC inhibition were unclear. This study evaluated whether HDAC inhibition can regulate PV electrical activity through calcium modulation. Whole-cell patch-clamp, confocal microscopic with fluorescence, and Western blot were used to evaluate electrophysiological characteristics and Ca2 + dynamics in isolated rabbit PV cardiomyocytes with and without MPT0E014 (a pan HDAC inhibitor), MS-275 (HDAC1 and 3 inhibitor), and MC-1568 (HDAC4 and 6 inhibitor) for 5 ~ 8 h. Atrial electrical activity and induced-AF (rapid atrial pacing and acetylcholine infusion) were measured in rabbits with and without MPT0E014 (10 mg/kg treated for 5 hours) in vivo. MPT0E014 (1 μM)-treated PV cardiomyocytes (n = 12) had slower beating rates (2.1 ± 0.2 vs. 2.8 ± 0.1 Hz, p <0.05) than control PV cardiomyocytes. However, control (n = 11) and MPT0E014 (1 μM)-treated (n = 12) SAN cardiomyocytes had similar beating rates (3.2 ± 0.2 vs. 2.9 ± 0.3 Hz). MS-275-treated PV cardiomyocytes (n = 12, 2.3 ± 0.2 Hz), but not MC-1568-treated PV cardiomyocytes (n = 14, 3.1 ± 0.3 Hz) had slower beating rates than control PV cardiomocytes. MPT0E014-treated PV cardiomyocytes (n = 14) had a lower frequency (2.4 ± 0.6 vs. 0.3 ± 0.1 spark/mm/s, p <0.05) of Ca2 + sparks than control PV (n = 17) cardiomyocytes. As compared to control, MPT0E014-treated PV cardiomyocytes had reduced Ca2 + transient amplitudes, sodium-calcium exchanger currents, and ryanodine receptor expressions. Moreover, MPT0E014-treated rabbits had less AF and shorter AF duration than control rabbits. In conclusions, HDAC inhibition reduced PV arrhythmogenesis and AF inducibility with modulation on calcium homeostasis.. All rights reserved.

AB - Pulmonary veins (PVs) play a critical role in the pathophysiology of atrial fibrillation (AF). Histone deacetylases (HDACs) are vital to calcium homeostasis and AF genesis. However, the electrophysiological effects of HDAC inhibition were unclear. This study evaluated whether HDAC inhibition can regulate PV electrical activity through calcium modulation. Whole-cell patch-clamp, confocal microscopic with fluorescence, and Western blot were used to evaluate electrophysiological characteristics and Ca2 + dynamics in isolated rabbit PV cardiomyocytes with and without MPT0E014 (a pan HDAC inhibitor), MS-275 (HDAC1 and 3 inhibitor), and MC-1568 (HDAC4 and 6 inhibitor) for 5 ~ 8 h. Atrial electrical activity and induced-AF (rapid atrial pacing and acetylcholine infusion) were measured in rabbits with and without MPT0E014 (10 mg/kg treated for 5 hours) in vivo. MPT0E014 (1 μM)-treated PV cardiomyocytes (n = 12) had slower beating rates (2.1 ± 0.2 vs. 2.8 ± 0.1 Hz, p <0.05) than control PV cardiomyocytes. However, control (n = 11) and MPT0E014 (1 μM)-treated (n = 12) SAN cardiomyocytes had similar beating rates (3.2 ± 0.2 vs. 2.9 ± 0.3 Hz). MS-275-treated PV cardiomyocytes (n = 12, 2.3 ± 0.2 Hz), but not MC-1568-treated PV cardiomyocytes (n = 14, 3.1 ± 0.3 Hz) had slower beating rates than control PV cardiomocytes. MPT0E014-treated PV cardiomyocytes (n = 14) had a lower frequency (2.4 ± 0.6 vs. 0.3 ± 0.1 spark/mm/s, p <0.05) of Ca2 + sparks than control PV (n = 17) cardiomyocytes. As compared to control, MPT0E014-treated PV cardiomyocytes had reduced Ca2 + transient amplitudes, sodium-calcium exchanger currents, and ryanodine receptor expressions. Moreover, MPT0E014-treated rabbits had less AF and shorter AF duration than control rabbits. In conclusions, HDAC inhibition reduced PV arrhythmogenesis and AF inducibility with modulation on calcium homeostasis.. All rights reserved.

KW - Atrial fibrillation

KW - Calcium homeostasis

KW - Histone deacetylase inhibition

KW - Pulmonary vein

UR - http://www.scopus.com/inward/record.url?scp=84920026023&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84920026023&partnerID=8YFLogxK

U2 - 10.1016/j.ijcard.2014.09.175

DO - 10.1016/j.ijcard.2014.09.175

M3 - Article

C2 - 25449511

AN - SCOPUS:84920026023

VL - 177

SP - 982

EP - 989

JO - International Journal of Cardiology

JF - International Journal of Cardiology

SN - 0167-5273

IS - 3

ER -